Wernicke–Korsakoff syndrome(Redirected from Wernicke-Korsakoff syndrome)
Wernicke–Korsakoff syndrome (WKS) is the combined presence of Wernicke's encephalopathy (WE) and Korsakoff's syndrome. Due to the close relationship between these two disorders, people with either are usually diagnosed with WKS, as a single syndrome.
|Synonyms||Korsakoff's psychosis, alcoholic encephalopathy|
The cause of the disorder is thiamine (vitamin B1) deficiency, which can cause a range of disorders including beriberi, Wernicke's encephalopathy, and Korsakoff's psychosis. These disorders may manifest together or separately. WKS is usually secondary to alcohol abuse. It mainly causes vision changes, ataxia and impaired memory.
Wernicke's encephalopathy and WKS are most commonly seen in people who are alcoholic, and only 20% of cases are identified before death. This failure in diagnosis of WE and thus treatment of the disease leads to death in approximately 20% of cases, while 75% are left with permanent brain damage associated with WKS. Of those affected, 25% require long-term institutionalization in order to receive effective care.
Signs and symptomsEdit
The syndrome is a combined manifestation of two namesake disorders, Wernicke's encephalopathy and Korsakoff's psychosis. It involves an acute Wernicke-encephalopathy phase, followed by the development of a chronic Korsakoff's syndrome phase.
WE is characterized by the presence of a triad of symptoms;
- Ocular disturbances (ophthalmoplegia)
- Changes in mental state (confusion)
- Unsteady stance and gait (ataxia)
This triad of symptoms results from a deficiency in vitamin B1 which is an essential coenzyme. The aforementioned changes in mental state occur in approximately 82% of patients' symptoms of which range from confusion, apathy, inability to concentrate, and a decrease in awareness of the immediate situation they are in. If left untreated, WE can lead to coma or death. In about 29% of patients, ocular disturbances consist of nystagmus and paralysis of the lateral rectus muscles or other muscles in the eye. A smaller percentage of patients experience a decrease in reaction time of the pupils to light stimuli and swelling of the optic disc which may be accompanied by retinal hemorrhage. Finally, the symptoms involving stance and gait occur in about 23% of patients and result from dysfunction in the cerebellum and vestibular system. Other symptoms that have been present in cases of WE are stupor, low blood pressure (hypotension), elevated heart rate (tachycardia), as well as hypothermia, epileptic seizures and a progressive loss of hearing.
Interestingly, about 19% of patients have none of the symptoms in the classic triad at first diagnosis of WE; however, usually one or more of the symptoms develops later as the disease progresses.
KS is described as an acute onset of severe memory impairment without any dysfunction in intellectual abilities. The DSM IV lists the following criteria for the diagnosis of Korsakoff's Syndrome:
In addition, the DSM-IV indicates that normal activities and function will be impaired by the memory deficits and that the experience of amnesia must occur outside of times where the individual is in a state of delirium, intoxification, or withdrawal. The criteria for diagnosis also maintain that there must be evidence that the amnesia is caused by the use of alcohol.
Despite the assertion that Korsakoff's syndrome must be caused by the use of alcohol, there have been several cases where it has developed from other instances of thiamine deficiency resulting from gross malnutrition due to conditions such as; stomach cancer, anorexia nervosa, and gastrectomy.
Several cases have been documented where Wernicke–Korsakoff syndrome has been seen on a large scale. In 1947, 52 cases of WKS were documented in a prisoner of war hospital in Singapore where the prisoners' diets included less than 1 mg of thiamine per day. Such cases provide an opportunity to gain an understanding of what effects this syndrome has on cognition. In this particular case, cognitive symptoms included insomnia, anxiety, difficulties in concentration, loss of memory for the immediate past, and gradual degeneration of mental state; consisting of confusion, confabulation, and hallucinations. In other cases of WKS, cognitive effects such as severely disrupted speech, giddiness, and heavy headedness have been documented. In addition to this, it has been noted that some patients displayed an inability to focus, and the inability of others to catch patients' attention.
In a study conducted in 2003 by Brand et al. on the cognitive effects of WKS, the researchers used a neuropsychological test battery which included tests of intelligence, speed of information processing, memory, executive function and cognitive estimation. They found that patients suffering from WKS showed impairments in all aspects of this test battery but most noticeably, on the cognitive estimation tasks. This task required subjects to estimate a physical quality such as size, weight, quantity or time (i.e. What is the average length of a shower?), of a particular item. Patients with WKS performed worse than normal control participants on all of the tasks in this category. The patients found estimations involving time to be the most difficult, whereas quantity was the easiest estimation to make. Additionally, the study included a category for classifying "bizarre" answers, which included any answer that was far outside of the normal range of expected responses. WKS patients did give answers that could fall into such a category and these included answers such as 15s or 1 hour for the estimated length of a shower, or 4 kg or 15 tonnes as the weight of a car.
As mentioned previously, the amnesic symptoms of WKS include both retrograde and anterograde amnesia. The retrograde deficit has been demonstrated through an inability of WKS patients to recall or recognize information for recent public events. The anterograde memory loss is demonstrated through deficits in tasks that involve encoding and then recalling lists of words and faces, as well as semantic learning tasks. WKS patients have also demonstrated difficulties in preservation as evidenced by a deficit in performance on the Wisconsin Card Sorting Test. The retrograde amnesia that accompanies WKS can extend as far back as twenty to thirty years, and there is generally a temporal gradient seen, where earlier memories are recalled better than more recent memories. It has been widely accepted that the critical structures that lead to the memory impairment in WKS are the mammillary bodies, and the thalamic regions. Despite the aforementioned memory deficits, non-declarative memory functions appear to be intact in WKS patients. This has been demonstrated through measures that assess perceptual priming.
Other studies have shown deficits in recognition memory and stimulus-reward associative functions in patients with WKS. The deficit in stimulus-reward functions was demonstrated by Oscar-Berman and Pulaski who presented patients with reinforcements for certain stimuli but not others, and then required the patients to distinguish the rewarded stimuli from the non-rewarded stimuli. WKS patients displayed significant deficits in this task. The researchers were also successful in displaying a deficit in recognition memory by having patients make a yes/no decision as to whether a stimulus was familiar (previously seen) or novel (not previously seen). The patients in this study also showed a significant deficit in their ability to perform this task.
People with WKS often show confabulation, spontaneous confabulation being seen more frequently than provoked confabulation. Spontaneous confabulations refer to incorrect memories that the patient holds to be true, and may act on, arising spontaneously without any provocation. Provoked confabulations can occur when a patient is cued to give a response, this may occur in test settings. The spontaneous confabulations viewed in WKS are thought to be produced by an impairment in source memory, where they are unable to remember the spatial and contextual information for an event, and thus may use irrelevant or old memory traces to fill in for the information that they cannot access. It has also been suggested that this behaviour may be due to executive dysfunction where they are unable to inhibit incorrect memories or because they are unable to shift their attention away from an incorrect response.
WKS is usually found in chronic alcoholics. Wernicke–Korsakoff syndrome results from thiamine deficiency. It is generally agreed that Wernicke's encephalopathy results from severe acute deficiency of thiamine (vitamin B1), whilst Korsakoff's psychosis is a chronic neurologic sequela of Wernicke's encephalopathy. The metabolically active form of thiamine is thiamine pyrophosphate, which plays a major role as a cofactor or coenzyme in glucose metabolism. The enzymes that are dependent on thiamine pyrophosphate are associated with the citric acid cycle (also known as the Krebs cycle), and catalyze the oxidation of pyruvate, α-ketoglutarate and branched chain amino acids. Thus, anything that encourages glucose metabolism will exacerbate an existing clinical or sub-clinical thiamine deficiency.
As stated above, Wernicke–Korsakoff syndrome in the United States is usually found in malnourished chronic alcoholics, though it is also found in patients who undergo prolonged intravenous (IV) therapy without vitamin B1 supplementation, gastric stapling, intensive care unit (ICU) stays or hunger strikes. In some regions, physicians have observed thiamine deficiency brought about by severe malnutrition, particularly in diets consisting mainly of polished rice, which is thiamine-deficient. The resulting nervous system ailment is called beriberi. In individuals with sub-clinical thiamine deficiency, a large dose of glucose (either as sweet food, etc. or glucose infusion) can precipitate the onset of overt encephalopathy.
Wernicke–Korsakoff syndrome in alcoholics particularly is associated with atrophy/infarction of specific regions of the brain, especially the mamillary bodies. Other regions include the anterior region of the thalamus (accounting for amnesic symptoms), the medial dorsal thalamus, the basal forebrain, the median and dorsal raphe nuclei, and the cerebellum.
The fact that gastrointestinal surgery can lead to the development of WKS was demonstrated in a study that was completed on three patients who recently undergone a gastrectomy. These patients had developed WKS but were not alcoholics and had never suffered from dietary deprivation. WKS developed between 2 and 20 years after the surgery. There were small dietary changes that contributed to the development of WKS but overall the lack of absorption of thiamine from the gastrointestinal tract was the cause. Therefore, it must be ensured that patients who have undergone gastrectomy have a proper education on dietary habits, and carefully monitor their thiamine intake. Additionally, an early diagnosis of WKS, should it develop, is very important.
Strong evidence suggests that ethanol interferes directly with thiamine uptake in the gastrointestinal tract. Ethanol also disrupts thiamine storage in the liver and the transformation of thiamine into its active form. The role of alcohol consumption in the development of WKS has been experimentally confirmed through studies in which rats were subjected to alcohol exposure and lower levels thiamine through a low-thiamine diet. In particular, studies have demonstrated that clinical signs of the neurological problems that result from thiamine deficiency develop faster in rats that have received alcohol and were also deficient in thiamine than rats who did not receive alcohol. In another study, it was found that rats that were chronically fed alcohol had significantly lower liver thiamine stores than control rats. This provides an explanation for why alcoholics with liver cirrhosis have a higher incidence of both thiamine deficiency and WKS.
Brain atrophy associated with WKS occurs in the following regions of the brain: the mammillary bodies, the thalamus, the periaqueductal grey, the walls of the 3rd ventricle, the floor of the 4th ventricle, the cerebellum, and the frontal lobe. In addition to the damage seen in these areas there have been reports of damage to cortex, although it was noted that this may be due to the direct toxic effects of alcohol as opposed to thiamine deficiency that has been attributed as the underlying cause of Wernicke-Korsakoff Syndrome.
The amnesia that is associated with this syndrome is a result of the atrophy in the structures of the diencephalon (the thalamus, hypothalamus and mammillary bodies), and is similar to amnesia that is presented as a result of other cases of damage to the medial temporal lobe. It has been argued that the memory impairments can occur as a result of damage along any part of the mammillo-thalamic tract, which explains how WKS can develop in patients with damage exclusively to either the thalamus or the mammillary bodies.
Diagnosis of Wernicke–Korsakoff syndrome is by clinical impression and can sometimes be confirmed by a formal neuropsychological assessment. Wernicke's encephalopathy typically presents with ataxia and nystagmus, and Korsakoff's psychosis with anterograde and retrograde amnesia and confabulation upon relevant lines of questioning.
Frequently, secondary to thiamine deficiency and subsequent cytotoxic edema in Wernicke's encephalopathy, patients will have marked degeneration of the mamillary bodies. Thiamine (vitamin B1) is an essential coenzyme in carbohydrate metabolism and is also a regulator of osmotic gradient. Its deficiency may cause swelling of the intracellular space and local disruption of the blood-brain barrier. Brain tissue is very sensitive to changes in electrolytes and pressure and edema can be cytotoxic. In Wernicke's this occurs specifically in the mammillary bodies, medial thalami, tectal plate, and periaqueductal areas. Sufferers may also exhibit a dislike for sunlight and so may wish to stay indoors with the lights off. The mechanism of this degeneration is unknown, but it supports the current neurological theory that the mammillary bodies play a role in various "memory circuits" within the brain. An example of a memory circuit is the Papez circuit.
The onset of Wernicke's encephalopathy is considered a medical emergency, and thus thiamine administration should be initiated immediately when the disease is suspected. Prompt administration of thiamine to patients with Wernicke's encephalopathy can prevent the disorder from developing into Wernicke–Korsakoff syndrome, or reduce its severity. Treatment can also reduce the progression of the deficits caused by WKS, but will not completely reverse existing deficits. WKS will continue to be present, at least partially, in 80% of patients. Patients suffering from WE should be given a minimum dose of 500 mg of thiamine hydrochloride, delivered by infusion over a 30-minute period for two to three days. If no response is seen then treatment should be discontinued but for those patients that do respond, treatment should be continued with a 250 mg dose delivered intravenously or intramuscularly for three to five days unless the patient stops improving. Such prompt administration of thiamine may be a life-saving measure. Banana bags, a bag of intravenous fluids containing vitamins and minerals, is one means of treatment.
As described, Korsakoff 's syndrome usually follows or accompanies Wernicke's encephalopathy. If treated quickly, it may be possible to prevent the development of Korsakoff's syndrome with thiamine treatments. This treatment is not guaranteed to be effective and the thiamine needs to be administered adequately in both dose and duration. A study on Wernicke-Korsakoff's syndrome showed that with consistent thiamine treatment there were noticeable improvements in mental status after only 2–3 weeks of therapy. Thus, there is hope that with treatment Wernicke's encephalopathy will not necessarily progress to WKS.
In order to reduce the risk of developing WKS it is important to limit the intake of alcohol or drink in order to ensure that proper nutrition needs are met. A healthy diet is imperative for proper nutrition which, in combination with thiamine supplements, may reduce the chance of developing WKS. This prevention method may specifically help heavy drinkers who refuse to or are unable to quit.
Internationally, the prevalence rates of WKS are relatively standard, being anywhere between zero and two percent. Despite this, specific sub-populations seem to have higher prevalence rates including people who are homeless, older individuals (especially those living alone or in isolation), and psychiatric inpatients. Additionally, studies show that prevalence is not connected to alcohol consumption per capita. For example, in France, a country that is well known for its consumption and production of wine, prevalence was only 0.4% in 1994, while Australia had a prevalence of 2.8%.
Carl Wernicke discovered Wernicke's encephalopathy in 1881. His first diagnosis noted symptoms including paralyzed eye movements, ataxia, and mental confusion. Also noticed were hemorrhages in the gray matter around the third and fourth ventricles and the cerebral aqueduct. Brain atrophy was only found upon post-mortem autopsy. Wernicke believed these hemorrhages were due to inflammation and thus the disease was named polioencephalitis haemorrhagica superior. Later, it was found that Wernicke's encephalopathy and Korsakoff's syndrome are products of the same cause.
Sergei Korsakoff was a Russian physician after whom the disease "Korsakoff's syndrome" is named. In the late 1800s Korsakoff was studying long-term alcoholic patients and began to notice a decline in their memory function. At the 13th International Medical Congress in Moscow in 1897, Korsakoff presented a report called: "On a special form of mental illness combined with degenerative polyneuritis". After the presentation of this report the term "Korsakoff's syndrome" was coined.
Although WE and KS were discovered separately, these two syndromes are usually referred to under one name, Wernicke–Korsakoff syndrome, due to the fact that they are part of the same cause and because the onset of KS usually follows WE if left untreated.
Society and cultureEdit
- MedlinePlus Encyclopedia Wernicke-Korsakoff syndrome
- Thomson, Allan D.; Marshall, E. Jane (2006). "The natural history and pathophysiology of Wernicke's Encephalopathy and Korsakoff's Psychosis". Alcohol and Alcoholism. 41 (2): 151–8. doi:10.1093/alcalc/agh249. PMID 16384871.
- Vetreno, Ryan Peter (2011). Thiamine deficiency-induced neurodegeneration and neurogenesis (PhD Thesis). Binghampton University. ISBN 978-1-124-75696-7. OCLC 781626781.[page needed]
- Sechi, GianPietro; Serra, Alessandro (2007). "Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management". The Lancet Neurology. 6 (5): 442–55. doi:10.1016/S1474-4422(07)70104-7. PMID 17434099.
- Kyoko Konishi. (2009) The Cognitive Profile of Elderly Korsakoff's Syndrome Patients.[page needed]
- Ingram, V.; Kelly, M.; Grammer, G. "Wernicke-Korsakoff Syndrome Following Uvulopalatopharyngoplasty for Sleep Apnea". in "Abstracts Presented at the Thirty-First Annual International Neuropsychological Society Conference, February 5–8, 2003 Honolulu, Hawaii". Journal of the International Neuropsychological Society. 9 (2): 135–330. 2003. doi:10.1017/S1355617703920017.
- Thomson, Allan D.; Cook, Christopher C. H.; Guerrini, Irene; Sheedy, Donna; Harper, Clive; Marshall, E. Jane (2008). "Review: Wernicke's encephalopathy revisited: Translation of the case history section of the original manuscript by Carl Wernicke 'Lehrbuch der Gehirnkrankheiten fur Aerzte and Studirende' (1881) with a commentary". Alcohol and Alcoholism. 43 (2): 174–9. doi:10.1093/alcalc/agm144. PMID 18056751.
- Brand, Matthias; Fujiwara, Esther; Kalbe, Elke; Steingass, Hans-Peter; Kessler, Josef; Markowitsch, Hans J. (2003). "Cognitive Estimation and Affective Judgments in Alcoholic Korsakoff Patients". Journal of Clinical and Experimental Neuropsychology. 25 (3): 324–34. doi:10.1076/jcen.25.3.324.13802. PMID 12916646.
- Kopelman, M. D.; Thomson, A. D.; Guerrini, I.; Marshall, E. J. (2009). "The Korsakoff Syndrome: Clinical Aspects, Psychology and Treatment". Alcohol and Alcoholism. 44 (2): 148–54. doi:10.1093/alcalc/agn118. PMID 19151162.
- Oscar-Berman, Marlene; Pulaski, Joan L. (1997). "Associative learning and recognition memory in alcoholic Korsakoff patients". Neuropsychology. 11 (2): 282–9. doi:10.1037/0894-418.104.22.1682. PMID 9110334.
- Kessels, Roy P. C.; Kortrijk, Hans E.; Wester, Arie J.; Nys, Gudrun M. S. (2008). "Confabulation behavior and false memories in Korsakoff's syndrome: Role of source memory and executive functioning". Psychiatry and Clinical Neurosciences. 62 (2): 220–5. doi:10.1111/j.1440-1819.2008.01758.x. PMID 18412846.
- Zimitat, Craig; Nixon, Peter F. (1999). "Glucose loading precipitates acute encephalopathy in thiamin-deficient rats". Metabolic Brain Disease. 14 (1): 1–20. doi:10.1023/A:1020653312697. PMID 10348310.
- Navarro, Darren; Zwingmann, Claudia; Chatauret, Nicolas; Butterworth, Roger F. (2008). "Glucose loading precipitates focal lactic acidosis in the vulnerable medial thalamus of thiamine-deficient rats". Metabolic Brain Disease. 23 (1): 115–22. doi:10.1007/s11011-007-9076-z. PMID 18034292.
- Watson, A. J. S.; Walker, J. F.; Tomkin, G. H.; Finn, M. M. R.; Keogh, J. A. B. (1981). "Acute Wernickes Encephalopathy precipitated by glucose loading". Irish Journal of Medical Science. 150 (10): 301–3. doi:10.1007/BF02938260. PMID 7319764.
- Mann, Karl; Agartz, Ingrid; Harper, Clive; Shoaf, Susan; Rawlings, Robert R.; Momenan, Reza; Hommer, Daniel W.; Pfefferbaum, Adolf; Sullivan, Edith V.; Anton, Raymond F.; Drobes, David J.; George, Mark S.; Bares, Roland; Machulla, Hans-Juergen; Mundle, Goetz; Reimold, Matthias; Heinz, Andreas (2001). "Neuroimaging in Alcoholism: Ethanol and Brain Damage". Alcoholism: Clinical and Experimental Research. 25 (5 Suppl ISBRA): 104S–109S. doi:10.1111/j.1530-0277.2001.tb02383.x. PMID 11391058.
- Butterworth, RF (1993). "Pathophysiology of cerebellar dysfunction in the Wernicke-Korsakoff syndrome". The Canadian Journal of Neurological Sciences. 20 Suppl 3: S123–6. PMID 8334588. INIST:4778798.
- Nixon, Peter F.; Kaczmarek, M. Jan; Tate, Jill; Kerr, Ray A.; Price, John (1984). "An erythrocyte transketolase isoenzyme pattern associated with the Wernicke-Korsakoff syndrome". European Journal of Clinical Investigation. 14 (4): 278–81. doi:10.1111/j.1365-2362.1984.tb01181.x. PMID 6434322.
- Shimomura, Tatsuo; Mori, Etsuro; Hirono, Nobutsugu; Imamura, Toru; Yamashita, Hikari (1998). "Development of Wernicke-Korsakoff syndrome after long intervals following gastrectomy". Archives of Neurology. 55 (9): 1242–5. doi:10.1001/archneur.55.9.1242. PMID 9740119.
- Todd, Kathryn G.; Hazell, Alan S.; Butterworth, Roger F. (1999). "Alcohol-thiamine interactions: an update on the pathogenesis of Wernicke encephalopathy". Addiction Biology. 4 (3): 261–72. doi:10.1080/13556219971470. PMID 20575793.
- He, Xiaohua; Sullivan, Edith V; Stankovic, Roger K; Harper, Clive G; Pfefferbaum, Adolf (2007). "Interaction of Thiamine Deficiency and Voluntary Alcohol Consumption Disrupts Rat Corpus Callosum Ultrastructure". Neuropsychopharmacology. 32 (10): 2207–16. doi:10.1038/sj.npp.1301332. PMID 17299515.
- Caulo, M. (2005). "Functional MRI study of diencephalic amnesia in Wernicke-Korsakoff syndrome". Brain. 128 (7): 1584–94. doi:10.1093/brain/awh496. PMID 15817513.
- Victor, M; Adams, RD; Collins, GH (1971). "The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations". Contemporary Neurology Series. 7: 1–206. PMID 5162155.
- Jeffrey E Kelsey; D Jeffrey Newport & Charles B Nemeroff (2006). "Alcohol Use Disorders". Principles of Psychopharmacology for Mental Health Professionals. Wiley-Interscience. pp. 196–197. ISBN 978-0-471-79462-2.
- Merle A. Carter & Edward Bernstein (2005). "Acute and Chronic Alcohol Intoxication". In Elizabeth Mitchell & Ron Medzon. Introduction to Emergency Medicine. Lippincott Williams & Wilkins. p. 272. ISBN 978-0-7817-3200-0.
- Wernicke-Korsakoff Syndrome at eMedicine
- Harper, Clive; Fornes, Paul; Duyckaerts, Charles; Lecomte, Dominique; Hauw, Jean-Jacques (1995). "An international perspective on the prevalence of the Wernicke-Korsakoff syndrome". Metabolic Brain Disease. 10 (1): 17–24. doi:10.1007/BF01991779. PMID 7596325.